Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

A once-a-month oral contraceptive.

Kirtane AR, Hua T, Hayward A, Bajpayee A, Wahane A, Lopes A, Bensel T, Ma L, Stanczyk FZ, Brooks S, Gwynne D, Wainer J, Collins J, Tamang SM, Langer R, Traverso G.

Sci Transl Med. 2019 Dec 4;11(521). pii: eaay2602. doi: 10.1126/scitranslmed.aay2602.

PMID:
31801885
2.

Temperature-responsive biometamaterials for gastrointestinal applications.

Babaee S, Pajovic S, Kirtane AR, Shi J, Caffarel-Salvador E, Hess K, Collins JE, Tamang S, Wahane AV, Hayward AM, Mazdiyasni H, Langer R, Traverso G.

Sci Transl Med. 2019 Apr 17;11(488). pii: eaau8581. doi: 10.1126/scitranslmed.aau8581.

PMID:
30996082
3.

Changing the pill: developments toward the promise of an ultra-long-acting gastroretentive dosage form.

Altreuter DH, Kirtane AR, Grant T, Kruger C, Traverso G, Bellinger AM.

Expert Opin Drug Deliv. 2018 Dec;15(12):1189-1198. doi: 10.1080/17425247.2018.1544615. Epub 2018 Nov 13. Review.

4.

Scalable Gastric Resident Systems for Veterinary Application.

Hayward A, Bensel T, Mazdiyasni H, Rogner J, Kirtane AR, Lee YL, Hua T, Bajpayee A, Collins J, McDonnell S, Cleveland C, Lopes A, Wahane A, Langer R, Traverso G.

Sci Rep. 2018 Aug 7;8(1):11816. doi: 10.1038/s41598-018-30212-3.

5.

Genotype-targeted local therapy of glioma.

Shankar GM, Kirtane AR, Miller JJ, Mazdiyasni H, Rogner J, Tai T, Williams EA, Higuchi F, Juratli TA, Tateishi K, Koerner MVA, Tummala SS, Fink AL, Penson T, Schmidt SP, Wojtkiewicz GR, Baig A, Francis JM, Rinne ML, Batten JM, Batchelor TT, Brastianos PK, Curry WT Jr, Barker FG 2nd, Jordan JT, Iafrate AJ, Chi AS, Lennerz JK, Meyerson M, Langer R, Wakimoto H, Traverso G, Cahill DP.

Proc Natl Acad Sci U S A. 2018 Sep 4;115(36):E8388-E8394. doi: 10.1073/pnas.1805751115. Epub 2018 Aug 6.

6.

Convergence for Translation: Drug-Delivery Research in Multidisciplinary Teams.

Traverso G, Kirtane AR, Schoellhammer CM, Langer R.

Angew Chem Int Ed Engl. 2018 Apr 9;57(16):4156-4163. doi: 10.1002/anie.201712512. Epub 2018 Mar 9. Review.

PMID:
29520902
7.

Development of an oral once-weekly drug delivery system for HIV antiretroviral therapy.

Kirtane AR, Abouzid O, Minahan D, Bensel T, Hill AL, Selinger C, Bershteyn A, Craig M, Mo SS, Mazdiyasni H, Cleveland C, Rogner J, Lee YL, Booth L, Javid F, Wu SJ, Grant T, Bellinger AM, Nikolic B, Hayward A, Wood L, Eckhoff PA, Nowak MA, Langer R, Traverso G.

Nat Commun. 2018 Jan 9;9(1):2. doi: 10.1038/s41467-017-02294-6.

8.

Triggerable tough hydrogels for gastric resident dosage forms.

Liu J, Pang Y, Zhang S, Cleveland C, Yin X, Booth L, Lin J, Lucy Lee YA, Mazdiyasni H, Saxton S, Kirtane AR, Erlach TV, Rogner J, Langer R, Traverso G.

Nat Commun. 2017 Jul 25;8(1):124. doi: 10.1038/s41467-017-00144-z.

9.

Triptolide suppresses the in vitro and in vivo growth of lung cancer cells by targeting hyaluronan-CD44/RHAMM signaling.

Song JM, Molla K, Anandharaj A, Cornax I, O Sullivan MG, Kirtane AR, Panyam J, Kassie F.

Oncotarget. 2017 Apr 18;8(16):26927-26940. doi: 10.18632/oncotarget.15879.

10.

Evaluation of Vaginal Drug Levels and Safety of a Locally Administered Glycerol Monolaurate Cream in Rhesus Macaques.

Kirtane AR, Rothenberger MK, Frieberg A, Nephew K, Schultz-Darken N, Schmidt T, Reimann T, Haase AT, Panyam J.

J Pharm Sci. 2017 Jul;106(7):1821-1827. doi: 10.1016/j.xphs.2017.03.030. Epub 2017 Apr 4.

11.

Fibrinolytic Enzyme Cotherapy Improves Tumor Perfusion and Therapeutic Efficacy of Anticancer Nanomedicine.

Kirtane AR, Sadhukha T, Kim H, Khanna V, Koniar B, Panyam J.

Cancer Res. 2017 Mar 15;77(6):1465-1475. doi: 10.1158/0008-5472.CAN-16-1646. Epub 2017 Jan 20.

12.

Assessing the Benefits of Drug Delivery by Nanocarriers: A Partico/Pharmacokinetic Framework.

Siegel RA, Kirtane AR, Panyam J.

IEEE Trans Biomed Eng. 2017 Sep;64(9):2176-2185. doi: 10.1109/TBME.2016.2632733. Epub 2016 Nov 29.

PMID:
27913319
13.

Past, Present, and Future Drug Delivery Systems for Antiretrovirals.

Kirtane AR, Langer R, Traverso G.

J Pharm Sci. 2016 Dec;105(12):3471-3482. doi: 10.1016/j.xphs.2016.09.015. Epub 2016 Oct 19. Review.

PMID:
27771050
14.

Honokiol suppresses lung tumorigenesis by targeting EGFR and its downstream effectors.

Song JM, Anandharaj A, Upadhyaya P, Kirtane AR, Kim JH, Hong KH, Panyam J, Kassie F.

Oncotarget. 2016 Sep 6;7(36):57752-57769. doi: 10.18632/oncotarget.10759.

15.

Reformulating Tylocrebrine in Epidermal Growth Factor Receptor Targeted Polymeric Nanoparticles Improves Its Therapeutic Index.

Kirtane AR, Wong HL, Guru BR, Lis LG, Georg GI, Gurvich VJ, Panyam J.

Mol Pharm. 2015 Aug 3;12(8):2912-23. doi: 10.1021/acs.molpharmaceut.5b00173. Epub 2015 Jul 3.

16.

A pharmacokinetic model for quantifying the effect of vascular permeability on the choice of drug carrier: a framework for personalized nanomedicine.

Kirtane AR, Siegel RA, Panyam J.

J Pharm Sci. 2015 Mar;104(3):1174-86. doi: 10.1002/jps.24302. Epub 2015 Jan 12.

PMID:
25583443
17.

Intranasal delivery of liposomal indole-3-carbinol improves its pulmonary bioavailability.

Song JM, Kirtane AR, Upadhyaya P, Qian X, Balbo S, Teferi F, Panyam J, Kassie F.

Int J Pharm. 2014 Dec 30;477(1-2):96-101. doi: 10.1016/j.ijpharm.2014.10.018. Epub 2014 Oct 11.

18.

Enhanced photodynamic therapy and effective elimination of cancer stem cells using surfactant-polymer nanoparticles.

Usacheva M, Swaminathan SK, Kirtane AR, Panyam J.

Mol Pharm. 2014 Sep 2;11(9):3186-95. doi: 10.1021/mp5003619. Epub 2014 Aug 6.

PMID:
25061685
19.

Polymer nanoparticles: Weighing up gene delivery.

Kirtane AR, Panyam J.

Nat Nanotechnol. 2013 Nov;8(11):805-6. doi: 10.1038/nnano.2013.234. No abstract available.

PMID:
24202534
20.

Exploiting nanotechnology to overcome tumor drug resistance: Challenges and opportunities.

Kirtane AR, Kalscheuer SM, Panyam J.

Adv Drug Deliv Rev. 2013 Nov;65(13-14):1731-47. doi: 10.1016/j.addr.2013.09.001. Epub 2013 Sep 10. Review.

Supplemental Content

Loading ...
Support Center